Zenas BioPharma Announces Closing of Upsized USD 200 Mn Series C Preferred Stock Financing
The financing round was led by SR One along with NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences and Longitude Capital.
Global Pharma | 07/05/2024 | By Manvi | 843
LSL Pharma Group Signs Binding Agreement to Acquire Target
LSL Pharma Group has entered into a binding Letter of Intent (LOI) to acquire profitable privately held, Quebec-based competing contract drug manufacturer (CDMO), Target Co.
Global Pharma | 07/05/2024 | By Aishwarya | 680
Steriline to Showcase its Technologies in Pharma Industry in Achema 2024
Steriline, European manufacturer of standard and robotic lines for the aseptic processing of injectable drugs, has announced that it will exhibit its new technologies developed to upgrade its zero-loss philosophy.
Global Pharma | 07/05/2024 | By Aishwarya | 783
Azurity Pharmaceuticals Receives FDA Approval for Myhibbin
Mycophenolate mofetil, an antimetabolite immunosuppressant crucial in safeguarding transplanted organs from rejection by the body's immune system, is a vital medication for organ transplant recipients.
Global Pharma | 07/05/2024 | By Abha | 763
Remidio Marks Milestone with 1000th FOP-NM Fundus Camera Placement in US
The FOP-NM, hailed as the world's first smartphone-based non-mydriatic fundus camera, has been a game-changer, eliminating the need for patient dilation and rapidly transforming retinal examinations in the US.
Global Pharma | 07/05/2024 | By Abha | 1529
GIBF Announces Investment of USD 10 Million in Nectin Therapeutics
Guangzhou-Israel Biotechnology Fund (GIBF) has invested USD 10 million in Nectin Therapeutics Ltd., a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune-oncology treatments.
Global Pharma | 07/05/2024 | By Aishwarya | 644
Solvias to Build Biologics and Cell and Gene Therapy Testing Center
Solvias has been planning to expand its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C.
Global Pharma | 07/05/2024 | By Aishwarya | 652
This agreement is the second such agreement in as many months shows TCBP's commitment to its M&A strategy aimed at expanding its therapeutic platform.
Global Pharma | 06/05/2024 | By Manvi | 391
Inspira Technologies Commences Production of INSPIRA ART100 Medical Device
This manufacturing partner has initiated the production and assembly process for the first batch of INSPIRA ART100 devices.
Global Pharma | 06/05/2024 | By Abha | 927
This approval provides an alternative administration option for individuals experiencing dysphagia or difficulty swallowing.
Global Pharma | 06/05/2024 | By Abha | 447
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy